Hualan Biological EngineeringInc (002007) — Financial Flexibility Index
Hualan Biological EngineeringInc (002007) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥355.60 Million (operating CF CN¥319.46 Million minus capex CN¥36.14 Million) represents 0% of total liabilities (CN¥3.02 Billion). Also explore net asset growth rate of Hualan Biological EngineeringInc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hualan Biological EngineeringInc Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Hualan Biological EngineeringInc across 22 annual periods. Check Hualan Biological EngineeringInc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hualan Biological EngineeringInc (2003–2024)
Year-by-year free cash flow to debt coverage for Hualan Biological EngineeringInc. For the full company profile including market capitalisation, see Hualan Biological EngineeringInc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.53x | CN¥1.32 Billion | CN¥1.06 Billion | CN¥2.46 Billion | ▼ -31.7% |
| 2023 | 0.78x | CN¥2.10 Billion | CN¥1.35 Billion | CN¥2.68 Billion | ▲ +46.4% |
| 2022 | 0.53x | CN¥1.35 Billion | CN¥957.31 Million | CN¥2.53 Billion | ▼ -41.1% |
| 2021 | 0.91x | CN¥2.24 Billion | CN¥1.43 Billion | CN¥2.47 Billion | ▼ -9.7% |
| 2020 | 1.00x | CN¥1.95 Billion | CN¥1.33 Billion | CN¥1.94 Billion | ▼ -57.1% |
| 2019 | 2.34x | CN¥1.64 Billion | CN¥1.36 Billion | CN¥699.26 Million | ▲ +14.2% |
| 2018 | 2.05x | CN¥1.48 Billion | CN¥1.29 Billion | CN¥720.47 Million | ▲ +170.2% |
| 2017 | 0.76x | CN¥285.95 Million | CN¥177.42 Million | CN¥377.24 Million | ▼ -70.4% |
| 2016 | 2.56x | CN¥550.60 Million | CN¥329.94 Million | CN¥215.05 Million | ▼ -54.9% |
| 2015 | 5.67x | CN¥777.96 Million | CN¥548.62 Million | CN¥137.11 Million | ▲ +19.2% |
| 2014 | 4.76x | CN¥636.36 Million | CN¥497.15 Million | CN¥133.70 Million | ▲ +108.3% |
| 2013 | 2.29x | CN¥759.91 Million | CN¥510.70 Million | CN¥332.55 Million | ▼ -53.1% |
| 2012 | 4.87x | CN¥641.85 Million | CN¥494.69 Million | CN¥131.84 Million | ▲ +56.3% |
| 2011 | 3.11x | CN¥479.52 Million | CN¥335.93 Million | CN¥153.99 Million | ▼ -30.2% |
| 2010 | 4.46x | CN¥759.20 Million | CN¥609.53 Million | CN¥170.06 Million | ▼ -9.8% |
| 2009 | 4.95x | CN¥770.16 Million | CN¥607.73 Million | CN¥155.67 Million | ▲ +101.8% |
| 2008 | 2.45x | CN¥288.07 Million | CN¥161.18 Million | CN¥117.50 Million | ▲ +80.0% |
| 2007 | 1.36x | CN¥392.93 Million | CN¥179.02 Million | CN¥288.51 Million | ▼ -11.1% |
| 2006 | 1.53x | CN¥348.73 Million | CN¥131.43 Million | CN¥227.67 Million | ▲ +45.7% |
| 2005 | 1.05x | CN¥156.83 Million | CN¥98.24 Million | CN¥149.20 Million | ▲ +247.0% |
| 2004 | 0.30x | CN¥43.48 Million | CN¥21.48 Million | CN¥143.53 Million | ▲ +83.2% |
| 2003 | 0.17x | CN¥36.17 Million | CN¥3.35 Million | CN¥218.79 Million | — |